ICPT
INTERCEPT PHARMACEUTICALS INData as of 2023 Q3 (09-30) · 13F snapshot
Summary
INTERCEPT PHARMACEUTICALS IN (ICPT) is held by 5 tracked hedge-fund managers, a combined reported value of ~$32.79M; the largest are Renaissance Technologies, Izzy Englander, Ken Griffin. Data as of 2023 Q3, from public SEC 13F filings, delayed up to ~45 days.
Attention · MediumThis quarter · Quiet
Gurus holding5
Congress trades0
Price—no price
Sectors0
This quarter's moves
Top holderRenaissance TechnologiesNew0
Added0
Trimmed / sold0
Value $3.20M— of portfolio172,6002023 Q3
Value $1.55M— of portfolio83,8002023 Q3
Value $1.51M— of portfolio15,0002018 Q4
Value $1.36M— of portfolio97,7002022 Q3
Value $927.0K— of portfolio50,0002023 Q3
| Investor | Value | % of portfolio | Action |
|---|---|---|---|
| Ken GriffinCALL | $3.20M | — | — |
| Ken GriffinPUT | $1.55M | — | — |
| Steven CohenCALL | $1.51M | — | — |
| Izzy EnglanderCALL | $1.36M | — | — |
| Izzy EnglanderPUT | $927.0K | — | — |
Data from public SEC 13F & STOCK Act filings, delayed up to ~45 days, partial holdings only — for research, not investment advice.